Lucknow-based online drug supplier on NCB Mumbai’s radar

Lucknow : An online drug supplier, operating from the bustling and densely populated Khadra locality in Lucknow, has come under the scrutiny of the Narcotics Control Bureau (NCB) Mumbai unit. The NCB team conducted a search operation in the area to locate the supplier.

Senior officials involved in the investigation revealed that the role of a Lucknow-based online drug supplier came to light while tracing the origins of a significant consignment of Tramadol tablets recently confiscated in Mumbai. The Mumbai team discovered that the parcel containing Tramadol tablets had been dispatched from an address located in the Khadra locality of Lucknow.

According to officials, the Mumbai NCB team collaborated with their counterparts in Lucknow to conduct a thorough search operation within the narrow and bustling lanes of Khadra locality. However, their efforts to trace the supplier couldn’t bear desired results due to the complex geography of the area.

“Despite the joint efforts of the Mumbai team, the Lucknow NCB sleuths, and local law enforcement, the search proved unfruitful. The intricate network of narrow lanes in Khadra locality, coupled with the absence of a precise address and identity, made it exceptionally challenging to locate the individual,” said an official closely associated with the operation.

The official further said that Khadra’s maze-like layout, with its crisscrossing narrow lanes, can even baffle frequent visitors trying to find specific residences. Moreover, Khadra is predominantly inhabited by the Muslim community, with a majority being from the lower-income segment.

It’s worth noting that the NCB recently seized a consignment of 1.2 kg (equivalent to 3,840 tablets) of Tramadol in Mumbai. Tramadol is a controlled substance primarily used to manage pain. This opioid agonist medication is available in tablet or capsule form and has the potential to lead to opioid addiction, misuse, and abuse, eventually leading to overdose and fatalities.

In a related incident earlier this year, on January 14, the U.P. Special Task Force had exposed a racket involved in smuggling prohibited medicines to the United States from India. The racket involved receiving orders from international clients through various channels like WhatsApp, Skype, and the Dark Web. The task force seized a significant number of Tramadol tablets and Lupin-10 Zolpidem tablets—22,850 and 17,880 tablets respectively. The culprits, three in number, were apprehended from Durgapuri locality in the Nilmatha area, falling under the jurisdiction of the Cantt police station. These illicit medicines were concealed within packaging of herbal and ayurvedic medicines.

Related Posts

Annovis Bio receives US patent covering new crystalline form of buntanetap

Annovis Bio, Inc. (Annovis), a phase 3 clinical-stage biotechnology company developing the investigational oral therapy, buntanetap, for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), announced that…

Bengaluru: Medical devices worth ₹13.79 lakh seized in enforcement drive

The enforcement wing of Karnataka’s Food Safety and Drugs Control Department has seized medical devices and consumables worth ₹13.79 lakh from two establishments in Bengaluru’s Cottonpet area for alleged violations…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Annovis Bio receives US patent covering new crystalline form of buntanetap

Annovis Bio receives US patent covering new crystalline form of buntanetap

Bengaluru: Medical devices worth ₹13.79 lakh seized in enforcement drive

Bengaluru: Medical devices worth ₹13.79 lakh seized in enforcement drive

Yashoda Medicity Unveils T-Shirts & Finisher Medals ahead of Yashoda Half Marathon 4.0

Yashoda Medicity Unveils T-Shirts & Finisher Medals ahead of Yashoda Half Marathon 4.0

PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

PharmEasy sees need for early prevention and regular screening to stall risk of diabetes

Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

Saudi pharma company seeks Indian manufacturers for product registration, commercialisation in Saudi Arabia

From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels

From ‘Kidney Care’ to ‘Liver Detox’, Uttar Pradesh bans misleading supplement labels